Affordable Access

Publisher Website

US FDA outreach to the regenerative medicine community: challenges and opportunities.

Authors
Type
Published Article
Journal
Regenerative medicine
Publication Date
Volume
7
Issue
4
Pages
595–603
Identifiers
DOI: 10.2217/rme.12.36
PMID: 22817631
Source
Medline

Abstract

Advances in the field of regenerative medicine have yielded novel approaches to developing treatments for currently unmet medical needs. The regenerative medicine field is diverse, spanning many research and clinical disciplines; no single society or organization fully represents regenerative medicine. The US FDA maintains an active dialog with a variety of stakeholders to keep abreast of the latest available science, to anticipate regulatory challenges posed by the latest scientific developments and to educate stakeholders about regulatory expectations for product development. The diversity of stakeholders in this field makes this dialog challenging. This article provides an overview of some of the FDA's current outreach activities in this area. The FDA welcomes opportunities to enhance its interactions with the regenerative medicine community.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F